[Event Report] Special International Forum: The Importance of Vaccines and Japan’s Role in Global Health (October 22, 2021)
date : 11/1/2021
Tags: Vaccinations
Health and Global Policy Institute (HGPI) convened an online Special International Forum: “The Importance of Vaccines and Japan’s Role in Global Health.”
The importance of vaccines in the context of global health has started to take up more space in the vaccine policy debate than ever before. As the impact of COVID-19 is felt in developing, as well as developed countries, a global, collaborative framework (ACT-A: Access to COVID-19 Tools Accelerator) to accelerate access to tools related to COVID-19 has been launched. Through the COVAX Facility, a multilateral framework for the procurement and distribution of safe and approved vaccines has been established. Furthermore, international contributions are being made through bilateral vaccine donations. Japan has engaged in various international cooperation initiatives through its Strategy on Global Health Diplomacy, approved by the Cabinet in 2013, and the Basic Design for Peace and Health (Global Health Cooperation), created in 2015.
At the same time, the international supply of COVID-19 vaccines has been unevenly distributed, with middle- and high-income countries receiving more vaccines and low-income countries receiving far fewer. Recently, there have been calls around the world for vaccines to be classified as “Global Public Goods” and it is essential that we expand the conversation to promote public and stakeholder interest and understanding of international contributions and diplomatic issues related to COVID-19.
The Special International Forum focused on Japan’s global provision of COVID-19 vaccines, the COVAX Facility’s current status and prospects, and Japan’s future role in health diplomacy. Experts from industry, government, academia, and the private sector in Japan and abroad engaged in discussions on the significance of medicines, including vaccines, to global health and the role expected of Japan moving forward.
■Date: Friday, October 22, 2021, 15:30-18:00 JST
■Format: Zoom Webinar
■Participation Fee: Free
■Language: English and Japanese (simultaneous interpretation available)
■Host: Health and Global Policy Institute
■Co-host: The British Embassy Japan
■Program: (Titles omitted)
15:30-15:35 Opening Address (1)
Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
15:35-15:40 Opening Address (2)
Julia Longbottom (British Ambassador to Japan)
15:40-15:45 Event Overview
Ryoji Noritake (CEO & Board Member, Health and Global Policy Institute)
15:45-16:00 Keynote Speech (1) Lessons Learned from UK’s Vaccine Rollout and Global Health Strategy
Saul Walker (Deputy Head of COVID-19 Vaccines, Therapeutics and Diagnostics Strategy, Foreign Commonwealth and Development Office(FCDO), UK)
16:00-16:15 Keynote Speech (2) Japan’s International Collaboration Efforts in the COVID-19 Era
Satoshi Ezoe (Director, Global Health Policy Division, Ministry of Foreign Affairs, Japan)
Panelists:
Mihoko Kashiwakura (Head of East Asia Relations, Bill & Melinda Gates Foundation)
Keizo Takemi (Member of the House of Councilors; WHO Goodwill Ambassador for UHC)
Atsushi Sunami (President, The Sasakawa Peace Foundation)
Kayo Takuma (Professor, Tokyo Metropolitan University)
Suwit Wibulpolprasert (Senior Advisor, Thai Ministry of Health)
Moderator:
Joji Sugawara (Manager, Health and Global Policy Institute)
17:50-18:00 Closing Remarks
Noriko Furuya (Member of the House of Representatives; Acting Chairperson, Association for the Promotion of Improved Public Health, Parliamentary Group for Vaccines and Prevention)
*Please find out the brochure at the bottom of this website for more information.
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] “International comparison of dementia policies, research study on information dissemination.” (April 10, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-26
[Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
-
2024-05-01
[Registration Open] The Global Health Education Program (G-HEP) 2024 (May 1, 2024)
-
2024-05-02
[Announcement] Recruitment of the Health Policy Academy the 13th Session